Our Company

This website contains information on veterinary pharmaceutical and biological products based on international registration dossiers. The website may refer to products that are either not available in your country or are marketed under a different trade name. In addition, the safety and efficacy data and the withholding periods for a specific product may be different depending on local regulations. Please consult your veterinarian for further information.

Horses



Good equine care requires access to a full range of safe and effective products to preserve the health of these beautiful animals. Our equine line has been extended by the introduction of EQUILIS PREQUENZA, the vaccine providing protection against the latest strains of equine influenza, with one year immunity after revaccination.

PREVENILE is a single-dose chimera vaccine offering rapid onset of immunity and one year protection against west nile virus (WNV). A chimera vaccine is created by combining two similar viruses (flaviviruses). This vaccine is a tool against the deadly threat posed by WNV to equine populations in countries such as the USA and Canada. Equilis Strep E, registered in the EU against strangles, a frequent and potentially fatal disease in horses, reduces clinical signs and occurrence of lymph node abscessation. The cefquinome-based respiratory treatment, COBACTAN 4.5 for foal septicemia, is one of the latest additions to our pharmaceutical portfolio in this equine segment.